← Back to Discover
VR Adviser, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $3,298,051,614
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- APOGEE THERAPEUTICS INC · COM · 03770N101 · shares: $1,127,318,496
- ORUKA THERAPEUTICS INC · COM · 687604108 · shares: $394,805,893
- ERASCA INC · COM · 29479A108 · shares: $327,777,996
- SPYRE THERAPEUTICS INC · COM NEW · 00773J202 · shares: $265,048,073
- DIANTHUS THERAPEUTICS INC · COM · 252828108 · shares: $115,026,400
- OCULAR THERAPEUTIX INC · COM · 67576A100 · shares: $101,606,813
- DAMORA THERAPEUTICS INC · COM NEW · 36322Q206 · shares: $93,729,506
- SAVARA INC · COM · 805111101 · shares: $90,835,009
- JADE BIOSCIENCES INC · COM NEW · 008064206 · shares: $71,556,488
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $63,551,824
Reported holdings
33 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC | COM | 03770N101 | — | 8,493,321 shares | $1,127,318,496 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 4,148,428 shares | $394,805,893 |
| ERASCA INC | COM | 29479A108 | — | 17,891,812 shares | $327,777,996 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 2,985,448 shares | $265,048,073 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 1,180,000 shares | $115,026,400 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 10,346,926 shares | $101,606,813 |
| DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | — | 3,603,595 shares | $93,729,506 |
| SAVARA INC | COM | 805111101 | — | 14,745,943 shares | $90,835,009 |
| JADE BIOSCIENCES INC | COM NEW | 008064206 | — | 3,220,364 shares | $71,556,488 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 1,642,166 shares | $63,551,824 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 3,257,917 shares | $59,847,935 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 3,041,719 shares | $55,998,047 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 2,173,913 shares | $48,282,608 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 1,602,034 shares | $47,804,695 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 6,844,305 shares | $47,362,591 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 4,319,765 shares | $46,783,055 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 2,133,576 shares | $38,404,368 |
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | — | 6,434,990 shares | $37,966,441 |
| ADLAI NORTYE LTD | SPONSORED ADS | 00704R109 | — | 3,212,731 shares | $36,946,407 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 526,331 shares | $26,711,298 |
| CYBIN INC | COM NEW | 23256X407 | — | 3,851,654 shares | $25,459,433 |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | — | 1,379,965 shares | $25,129,163 |
| CENTURY THERAPEUTICS INC | COM | 15673T100 | — | 8,695,652 shares | $21,304,347 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 2,043,596 shares | $19,822,881 |
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | — | 4,982,124 shares | $18,682,965 |
| ACHIEVE LIFE SCIENCE INC | COM | 004468500 | — | 2,751,032 shares | $17,964,239 |
| PARABILIS MEDICINES INC | COM | 698955101 | — | 625,000 shares | $17,106,250 |
| SURROZEN INC | COM NEW | 86889P208 | — | 632,931 shares | $16,424,559 |
| KORRO BIO INC | COM | 500946108 | — | 1,009,500 shares | $13,305,210 |
| ALTO NEUROSCIENCE INC | COM SHS | 02157Q109 | — | 500,000 shares | $13,195,000 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 1,934,253 shares | $9,032,962 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 300,000 shares | $3,210,000 |
| INMED PHARMACEUTICALS INC | COM NEW | 457637700 | — | 32,685 shares | $50,662 |